Visualitzant O - Articles científics per títol

Machine Learning Based Microbiome Signature to Predict Inflammatory Bowel Disease Subtypes

Liñares Blanco, Jose; Fernandez-Lozano, Carlos; Seoane Fernández, Jose Antonio; Lopez-Campos, Guillermo (Frontiers Media, 2022-05-17)

Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes

Mosquera Orgueira, Adrián; Diaz Varela, Nicolas A; MONTORO, JULIA; Pérez-Encinas, Manuel; Mora, Elvira; Díaz-Beyá, Marina (Wolters Kluwer Health, 2023-10)

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis

Hernandez Sanchez, Alberto; González-Martínez, Teresa; Martínez-Elicegui, Javier; Pérez-Encinas, Manuel; Fox, Maria Laura; Mosquera Orgueira, Adrián; Arellano-Rodrigo, Eduardo (Wolters Kluwer Health, 2023-01)

Machine learning techniques to estimate the degree of binder activity of reclaimed asphalt pavement

Botella, Ramon; Lo Presti, Davide; Vasconcelos, Kamilla; Bernatowicz, Kinga; Martínez, Adriana H.; Miró, Rodrigo (Springer, 2022-04-16)

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Golan, Talia; Hammel, Pascal; Reni, Michele; Van Cutsem, Eric; Macarulla Mercadé, Teresa; Hall, Michael J (Massachusetts Medical Society, 2019-06-02)

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial

Selle, Frédéric; Bernard, Asselain; Marmé, Frederik; Lindemann, Kristina; PUJADE-LAURAINE, Eric; Scambia, Giovanni; OAKNIN, ANA (Elsevier, 2023-12)

Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety

Oaknin Benzaquen, Ana Mazaltob; Oza, Amit M.; Lorusso, Domenica; Dean, Andrew; Colombo, Nicoletta; Aghajanian, Carol (Wiley, 2021-10)

Management of advanced ovarian cancer in Spain: an expert Delphi consensus

Redondo Sanchez, Andres; Oaknin Benzaquen, Ana Mazaltob; Rubio, Maria Jesus; Barretina-Ginesta, Maria-Pilar; de Juan Ferre, Ana; Manso, Luis (BMC, 2021-05-26)

Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study

Tabernero Caturla, Josep; Velez, L; Trevino, T. L.; Grothey, Axel; Van Cutsem, Eric; Yaeger, Rona (Elsevier, 2021-12)

Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines

Grothey, Axel; Tabernero Caturla, Josep; Fakih, Marwan (Elsevier, 2021-08)

Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy

Muñoz de Nova, Jose Luis; Hernando Cubero, Jorge; Sampedro-Núñez, Miguel; Vázquez Benítez, Greissy Tibisay; Triviño-Ibañez, Eva-Maria; Del Olmo García, Maria Isabel; Barriuso, J.; Martin-Perez, Elena; Capdevila Castillon, Jaume (Baishideng Publishing Group, 2022-04-07)

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

Gillessen, Silke; Bossi, Alberto; Davis, Ian D.; Fizazi, Karim; James, Nicholas D.; Mateo Valderrama, Joaquim; de Bono, Johann S (Elsevier, 2023-03)

Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development

Steeghs, Neeltje; Hansen, Aaron; Garralda Cabanas, Elena; Park, Haeseong; Strauss, James; Hanna, Glenn (Wiley, 2022-11)

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Im, Seock-Ah; Cardoso, Fatima; Cortés Castan, Javier; Musolino, Antonio; Escriva de Romaní Muñoz, Santiago Ignacio; Saura Manich, Cristina; Rugo, Hope; Curigliano, Giuseppe (American Society of Clinical Oncology, 2023-01-10)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant VHIO - Articles científics per títol

Machine Learning Based Microbiome Signature to Predict Inflammatory Bowel Disease Subtypes

Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis

Machine learning techniques to estimate the degree of binder activity of reclaimed asphalt pavement

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial

Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety

Management of advanced ovarian cancer in Spain: an expert Delphi consensus

Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study

Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines

Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Mass Spectrometry-Based Proteomics Workflows in Cancer Research: The Relevance of Choosing the Right Steps

Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion

MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer

Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy

Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant VHIO - Articles científics per títol

Machine Learning Based Microbiome Signature to Predict Inflammatory Bowel Disease Subtypes ﻿

Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes ﻿

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis ﻿

Machine learning techniques to estimate the degree of binder activity of reclaimed asphalt pavement ﻿

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer ﻿

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial ﻿

Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety ﻿

Management of advanced ovarian cancer in Spain: an expert Delphi consensus ﻿

Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study ﻿

Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines ﻿

Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy ﻿

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 ﻿

Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development ﻿

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial ﻿

Mass Spectrometry-Based Proteomics Workflows in Cancer Research: The Relevance of Choosing the Right Steps ﻿

Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion ﻿

MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer ﻿

Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy ﻿

Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity ﻿

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Machine Learning Based Microbiome Signature to Predict Inflammatory Bowel Disease Subtypes

Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis

Machine learning techniques to estimate the degree of binder activity of reclaimed asphalt pavement

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial

Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety

Management of advanced ovarian cancer in Spain: an expert Delphi consensus

Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study

Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines

Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Mass Spectrometry-Based Proteomics Workflows in Cancer Research: The Relevance of Choosing the Right Steps

Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion

MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer

Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy

Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer